Verona Pharma plc (VRNA) Misses Q4 EPS by 3c

Verona Pharma plc (NASDAQ: VRNA) reported Q4 EPS of ($0.02), $0.03 worse than the analyst estimate of $0.01.

For earnings history and earnings-related data on Verona Pharma plc (VRNA) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• HCB shareholders approve Independent Bank's acquisition deal
• Accenture (ACN) Tops Q3 EPS by 8c, Misses on Revenue; Offers FY26 EPS Guidance